Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Excretion, Mass Balance, and Metabolism of [14C]LY3202626 in Humans: An Interplay of Microbial Reduction, Reabsorption, and Aldehyde Oxidase Oxidation That Leads to an Extended Excretion Profile

Kishore Katyayan, Ping Yi, Scott Monk and Kenneth Cassidy
Drug Metabolism and Disposition August 2020, 48 (8) 698-707; DOI: https://doi.org/10.1124/dmd.120.000009
Kishore Katyayan
Drug Disposition Eli Lilly and Company, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ping Yi
Drug Disposition Eli Lilly and Company, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Monk
Drug Disposition Eli Lilly and Company, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Cassidy
Drug Disposition Eli Lilly and Company, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 48 no. 8 698-707
DOI 
https://doi.org/10.1124/dmd.120.000009
PubMed 
32499340

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 12, 2020
  • Accepted April 22, 2020
  • Published online July 16, 2020.

Article Versions

  • Earlier version (June 4, 2020 - 05:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kishore Katyayan,
  2. Ping Yi1,
  3. Scott Monk, and
  4. Kenneth Cassidy
  1. Drug Disposition Eli Lilly and Company, Indianapolis, Indiana
  1. Address correspondence to:
    Dr. Kishore K. Katyayan, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. E-mail: kishore.katyayan{at}lilly.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: June 2020 to September 2023

AbstractFullPdf
Jun 202036519197
Jul 20202873862
Aug 20201653031
Sep 2020992123
Oct 2020711419
Nov 202055512
Dec 20204248
Jan 2021642023
Feb 202160128
Mar 202150810
Apr 202137510
May 20214927
Jun 20214979
Jul 2021181214
Aug 2021942525
Sep 202123618
Oct 20212369
Nov 202125723
Dec 202135022
Jan 202265631
Feb 202256521
Mar 202297442
Apr 202235621
May 202215326
Jun 202244724
Jul 202274443
Aug 202246323
Sep 2022114929
Oct 2022104729
Nov 202274734
Dec 202253022
Jan 202354924
Feb 202365425
Mar 2023116423
Apr 202315624
May 202356734
Jun 202337334
Jul 2023115953
Aug 202346033
Sep 202345428

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 48 (8)
Drug Metabolism and Disposition
Vol. 48, Issue 8
1 Aug 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Excretion, Mass Balance, and Metabolism of [14C]LY3202626 in Humans: An Interplay of Microbial Reduction, Reabsorption, and Aldehyde Oxidase Oxidation That Leads to an Extended Excretion Profile
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

LY3202626 Excretion, Mass Balance, and Metabolism in Human

Kishore Katyayan, Ping Yi, Scott Monk and Kenneth Cassidy
Drug Metabolism and Disposition August 1, 2020, 48 (8) 698-707; DOI: https://doi.org/10.1124/dmd.120.000009

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

LY3202626 Excretion, Mass Balance, and Metabolism in Human

Kishore Katyayan, Ping Yi, Scott Monk and Kenneth Cassidy
Drug Metabolism and Disposition August 1, 2020, 48 (8) 698-707; DOI: https://doi.org/10.1124/dmd.120.000009
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PK-PD studies of active ingredient in CH-I
  • IVIVE of aldehyde oxidase-mediated clearance
  • ALTBio Consortium developed for drug metabolism research.
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics